Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 454
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06662773 | Drug-Drug Interaction (DDI) Study for TQB3616 | ||
| NCT06115902 | A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer | ||
| NCT06644417 | Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection | ||
| NCT05375461 | TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail | ||
| NCT06851442 | Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer | ||
| NCT04925141 | A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP) | ||
| NCT04964479 | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) | ||
| NCT03461627 | Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma | ||
| NCT03456466 | Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma | ||
| NCT04063683 | Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. | ||
| NCT01926288 | Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B | ||
| NCT02469883 | A Study of Sinotecean on Tolerance and Pharmacokinetics | ||
| NCT06859931 | Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) | ||
| NCT05997342 | A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor | ||
| NCT04691388 | A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor | ||
| NCT05807880 | Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma | ||
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | ||
| NCT03847246 | Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers | ||
| NCT06900920 | A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia | ||
| NCT01846650 | A Bioequivalence Study of Capecitabine Tablets | ||
| NCT04619563 | A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients | ||
| NCT07047365 | TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT04326348 | A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH） | ||
| NCT07293390 | A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects | ||
| NCT07052097 | Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis | ||
| NCT07697443 | Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects | ||
| NCT06789289 | A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | ||
| NCT06143423 | A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects. | ||
| NCT05353179 | Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers | ||
| NCT04842526 | Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study | ||
| NCT03706287 | Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC | ||
| NCT07512583 | Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors | ||
| NCT06010537 | Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle | ||
| NCT07653685 | A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer | ||
| NCT05800418 | Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers | ||
| NCT04944043 | A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease | ||
| NCT04080843 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | ||
| NCT04216082 | A Study of Anlotinib in Subjects With Advanced Malignancy | ||
| NCT03998085 | Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC | ||
| NCT05646758 | A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects | ||
| NCT07464587 | Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease | ||
| NCT06024915 | A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets | ||
| NCT04854668 | A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer | ||
| NCT06230588 | A Clinical Trial of TQH3906 Capsules in Healthy Volunteers | ||
| NCT06415903 | A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT04809142 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer | ||
| NCT05365178 | To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer | ||
| NCT07398859 | Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis | ||
| NCT05001971 | Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy | ||
| NCT01795716 | Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body |
